# Refoxy Pharma

Private

Cologne

Healthcare & Life Sciences [Refoxy Website](https://www.refoxy.com/)

Last Round

Seed

Dec 4, 2024

Total Funding Raised

$15.4M

Momentum

Top 25% of companies Caplight tracks

## Company Overview

Refoxy Pharma is a biotechnology company developing small molecule activators of the FOXO3 transcription factor for the treatment of age-related diseases, with an initial focus on idiopathic pulmonary fibrosis.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

drug discovery, biotechnology, idiopathic pulmonary fibrosis, IPF, small molecule, FOXO3, geroscience, longevity research, fibrosis, preclinical research, phenotypic screening, drug pipeline, biotech startup, longevity biotech, therapeutic candidate

## Historical Pricing

Historical view of private secondary pricing and transaction trends.

## Refoxy Pharma Comparables

Compare Refoxy Pharma with similar companies based on industry and business-model similarity.

| Company | Similarity | Market Cap |
| --- | --- | --- |
| [Isterian Biotech](/content/company/isterian/index.html) | 81% | Unlock |
| [Oorja Bio, Inc.](/content/company/oorja-bio-1/index.html) | 78% | Unlock |
| [Mediar Therapeutics](/content/company/mediar-therapeutics/index.html) | 71% | Unlock |
| Comparable company | 50% | Unlock |

## Refoxy Pharma Funding Rounds

Historical fundraising activity

| Round | Date | Amount Raised | Valuation | Investors | Sources |
| --- | --- | --- | --- | --- | --- |
| Seed | Dec 4, 2024 | Unlock | Unlock | Unlock | Unlock |
| Seed | Nov 30, 2022 | Unlock | Unlock | Unlock | Unlock |
| Seed | Aug 1, 2021 | Unlock | Unlock | Unlock | Unlock |

## Key People

Founding team and executive leadership

Victor Bustos

Co-Founder and CEO

## Refoxy Pharma Investors

| Investor | Rounds |
| --- | --- |
| [NRW.Venture](/content/investor/nrwbank-de/index.html) | Seed |
| [Boehringer Ingelheim](/content/investor/boehringer-ingelheim/index.html) | Seed |
| [NRW.Bank](/content/investor/nrwbank/index.html) | Seed |
| [Korify Capital](/content/investor/korifycapital/index.html) | Seed |
| [Boehringer Ingelheim Venture Fund](/content/investor/boehringer-ingelheim-venture/index.html) | Seed |
| [High-Tech Gründerfonds](/content/investor/htgf/index.html) | Seed |

## Market signals

- May 11, 2026: Monthly visitors grew 300% MoM, reaching 977.
- Dec 4, 2024: $9.7M round led by Boehringer Ingelheim.

## Refoxy Pharma Filings

| Typed | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
| --- | --- | --- | --- | --- | --- | --- |
| Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |

## Frequently Asked Questions

- Is Refoxy Pharma a public or private company?
- What is the current stock price of Refoxy Pharma?
- How much is Refoxy Pharma worth (valuation)?
- Can I buy Refoxy Pharma stock?
- When was Refoxy Pharma's last funding round?
- Who are the main investors in Refoxy Pharma?
- Will Refoxy Pharma IPO soon?
- How can I track Refoxy Pharma secondary market activity?

## Firmographic Details

Headquarters: Cologne

Employee Range: 12

Year Founded: 2020

Last Funding: Dec 4, 2024